Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Trajectory of COVID-19 epidemic in Europe

View ORCID ProfileMarco Colombo, Joseph Mellor, View ORCID ProfileHelen M Colhoun, M Gabriela M Gomes, View ORCID ProfilePaul M McKeigue
doi: https://doi.org/10.1101/2020.09.26.20202267
Marco Colombo
1Institute of Genetics and Molecular Medicine, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco Colombo
Joseph Mellor
2Usher Institute, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Helen M Colhoun
1Institute of Genetics and Molecular Medicine, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Helen M Colhoun
M Gabriela M Gomes
3Department of Mathematics & Statistics, University of Strathclyde, Glasgow, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul M McKeigue
2Usher Institute, College of Medicine & Veterinary Medicine, University of Edinburgh, Edinburgh, Scotland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul M McKeigue
  • For correspondence: paul.mckeigue@ed.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Summary

The classic Susceptible-Infected-Recovered model formulated by Kermack and McKendrick [1] assumes that all individuals in the population are equally susceptible to infection. From fitting such a model to the trajectory of mortality from COVID-19 in 11 European countries up to 4 May 2020 Flaxman et al. concluded that “major non-pharmaceutical interventions – and lockdowns in particular – have had a large effect on reducing transmission” [2]. We show that relaxing the assumption of homogeneity to allow for individual variation in susceptibility or connectivity gives a model that has better fit to the data and more accurate 14-day forward prediction of mortality. Allowing for heterogeneity reduces the estimate of “counterfactual” deaths that would have occurred if there had been no interventions from 3.2 million to 262,000, implying that most of the slowing and reversal of COVID-19 mortality is explained by the build-up of herd immunity. The estimate of the herd immunity threshold depends on the value specified for the infection fatality ratio (IFR): a value of 0.3% for the IFR gives 15% for the average herd immunity threshold.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Self-audit for research not involving human subjects as specified by Usher Research Ethics Group, University of Edinburgh

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ARISING FROM S. Flaxman et al. Nature

  • https://www.nature.com/articles/s41586-020-2405-7 (2020)

Data Availability

All data and modelling code are freely available at the URL given below.

https://github.com/mcol/covid19model

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted September 28, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Trajectory of COVID-19 epidemic in Europe
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Trajectory of COVID-19 epidemic in Europe
Marco Colombo, Joseph Mellor, Helen M Colhoun, M Gabriela M Gomes, Paul M McKeigue
medRxiv 2020.09.26.20202267; doi: https://doi.org/10.1101/2020.09.26.20202267
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Trajectory of COVID-19 epidemic in Europe
Marco Colombo, Joseph Mellor, Helen M Colhoun, M Gabriela M Gomes, Paul M McKeigue
medRxiv 2020.09.26.20202267; doi: https://doi.org/10.1101/2020.09.26.20202267

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1254)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (537)
  • Epidemiology (10043)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2477)
  • Geriatric Medicine (239)
  • Health Economics (482)
  • Health Informatics (1650)
  • Health Policy (756)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11886)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2298)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1255)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (736)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2291)
  • Public and Global Health (4849)
  • Radiology and Imaging (844)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (654)
  • Rheumatology (288)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (271)
  • Toxicology (44)
  • Transplantation (130)
  • Urology (100)